Biochrom AG s antibiotics solutions: working concentration. Biochrom AG Information, November 19, 2010

Similar documents
Antibiotic Resistance in Bacteria

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antimicrobials & Resistance

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Antibiotics & Resistance

Antibacterial susceptibility testing

Antimicrobial Therapy

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

ANTIBIOTICS IN PLASMA

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Antimicrobial agents

Controlling Microbial Growth in the Body: Antimicrobial Drugs

An#bio#cs and challenges in the wake of superbugs

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Microbiology ( Bacteriology) sheet # 7

Principles of Antimicrobial therapy

Antimicrobial agents. are chemicals active against microorganisms

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

Antimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Protein Synthesis Inhibitors

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Nocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda

Mechanism of antibiotic resistance

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

bacteria fungi HOW? WHAT? protozoa virus Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Chemotherapeutic Agents

WHY IS THIS IMPORTANT?

Health Products Regulatory Authority

Introduction to antimicrobial agents

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobials. Antimicrobials

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

control microbial growth in vivo

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory NEOSPORIN SKIN / ANTIBIOTIC OINTMENT

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

CSLO3. Distinguish between mechanisms of physical and chemical agents to control microbial populations.

SELECT NEWS. Florfenicol Monograph: Injectable & Oral Therapy for Swine

Other Beta - lactam Antibiotics

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3)

Chapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L.

Antibacterial Agents & Conditions. Stijn van der Veen

Foundations in Microbiology Seventh Edition

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified)

Overview. There are commonly found arrangements of bacteria based on their division. Spheres, Rods, Spirals

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

Responsible use of antimicrobials

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall

Search for Antimicrobial Agents Produced by the Soil Actinomycetes

Rutgers University, New Brunswick, N. J.) All these cultures proved to be highly active against mycobacteria.

Is erythromycin bactericidal

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

بسم هللا الرحمن الرحيم

CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Physical & Chemical Means of Controlling Contamination in Plant Tissue Culture. Dr. Gary Seckinger Dr. Kenneth C. Torres PhytoTechnology Laboratories

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES THE AMINOGLYCOSIDES:

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle

Antibiotics (2): - Before you start: this lecture has a lot of names and things get entangled together, but I

CORAL ESSENTIALS INFORMATION

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

Antimicrobial Resistance

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Topical Antibiotic Update. Brad Sutton, O.D., F.A.A.O. Indiana University School of Optometry Indianapolis Eye Care Center No financial disclosures

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

SUMMARY OF PRODUCT CHARACTERISTICS

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

Approach to pediatric Antibiotics

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

Controlling microbial growth in vivo by using antimicrobial agents. Dr. Nasser M. Kaplan Medical Microbiology JUST, Irbid, Jordan

Summary of Product Characteristics

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Transcription:

Biochrom AG s antibiotics solutions: Up-to to-date overview regarding of action, performance and working concentration Biochrom AG Information, November 19, 2010 Cell culture media allow not only cells but also foreign germs, such as bacteria or fungi, to grow ideally. This growth of foreign organisms, which is also referred to as contamination, results nearly always in the loss of the respective cell culture. Only the preventive use of antibiotics or sterile working conditions may prevent contaminations. Originally, antibiotics (Greek anti : against; biotikos : relating to living organisms) was the term for low-molecular metabolites of microorganisms that act as growth inhibitors against other microorganisms or kill the latter. Today, the term antibiotics comprises all substances (also virostatics and chemotherapeutics) that are effective against any type of microorganism (bacteria, viruses, fungi), no matter if they are of low or high molecular nature or if they were produced synthetically or by the microorganisms themselves. Antibiotics may be distinguished according to their effectiveness, chemical structure or their action. Within the framework of cell culture, it is rather effectiveness that is of importance: on the one hand, there are bacteriostatic antibiotics that only inhibit the growth of microorganisms, but do not kill them. On the other hand, there are bactericidal antibiotics, which not only inhibit growth, but additionally kill microorganisms. Penicillin and Streptomycin are those two antibiotics that are used in cell culture on a routine basis. The cocktail referred to as Pen/Strep is effective against Gram-negative and Grampositive bacteria, as well as against mycobacteria. Both antibiotics remain, however, stable in the culture for only a period of three days. If the cell culture is to be kept for a longer period of time, Pen/Strep has to be added again or replaced by more stable antibiotics. As Biochrom AG offers different types of antibiotics, the following overview covers some important criteria, such as working concentration, stability and toxicity, in accordance with latest research findings. The last part includes a short FAQ section regarding antibiotics. 1 Classification of antibiotics Antibiotics can be classified according to the following criteria: chemical structure β-lactam, s, macrolides, polypeptides, tetracyclines etc. effectiveness 1. bacteriostatic antibiotics (inhibit growth of microorganisms, but do not kill them) 2. bactericidal antibiotics (inhibit growth of microorganisms and kill them) In the case of bactericidal antibiotics, one may further distinguish between primary and secondary bactericides. Primary bactericides are effective against nonproliferating bacteria, while secondary bactericides are effective only against dividing bacteria. 1. inhibition of cell wall synthesis: e.g. β-lactam, such as Penicillin and glycopeptides Biochrom AG Internet: www.biochrom.de page 1 of 7

2. inhibition of protein biosynthesis: e.g. s, tetracyclines, macrolides and others. A number of Biochrom antibiotics belong to the group of s, such as Gentamycin sulfate, Kanamycin, Neomycin, and Streptomycin. 3. disturbance of cell membrane function: e.g. polyene macrolides, such as amphotericin B, and peptides, such as Polymyxin B-sulfate. 4. interference with bacterial DNA or RNA: e.g. rifampicin. 2 Details on the individual antibiotics offered by Biochrom AG table 1 and 2: details on the antibiotics Amphotericin B and Bacitracin Amphotericin B A 2612 (250 µg/ml) A 2610 (lyophilised) 1x (6x5 ml) molecular formula C 47H 73NO 17 CAS no. 1397-89-3 molecular weight 924.1 g/mol polyene macrolide, antimycotic fungi and yeasts, no on bacteria working concentration 2.5-3 µg/ml maximum solubility 40 mg/ml in DMSO, insoluble in H 2O, soluble in H 2O with Na-deoxycholate, storage at -20 C stability 1 3 days at 37 C in solution 30 µg/ml Disturbs cell membrane permeability by binding to cell membrane sterols of fungi. Effective against, inter alia, Candida types. By binding to planar sterols, such as cholesterol, it may modify the cell membrane, which becomes permeable to ions (K +, Mg 2+ ) 2 and other low-molecular substances (e.g. amino acids, sugar, nucleotides) 3. Streptomyces nodosus Bacitracin Biochrom AG offers the combination Bacitracin/Neomycin (see Neomycin) molecular formula C 66H 103N 17O 16S CAS no. 1405-87-4 molecular weight 1422.72 g/mol (Bacitracin A), mixture of 9 Bacitracins polypeptide mainly on Gram-positive bacteria, but also on Mycoplasma and Neisseria working concentration 0.1-1 mg/ml maximum solubility 100 mg/ml in H 2O or ethanol, storage at -20 C stability 1 quickly inactive at 25 C in a ph range of > 5 Inhibits cell wall synthesis of Gram-positive bacteria by binding to bactoprenyl pyrophosphate 4. Bacillus licheniformis 1 Lindl, T. and Bauer, J. (2008): Zell- und Gewebekultur, 6 th edition, Spektrum Akademischer Verlag, Heidelberg. 2 Ellis, D. (2002): Amphotericin B: spectrum and resistance, J. Antimicrob Chem 49: 7-10. 3 Holz, R. W. (1979): Antibiotics V, 313 ff, F. E. Hahn ed, Sringer Verlag Berlin, Heidelberg, New York. 4 Scogin, D. A. et al. (1980): Binding of nickel and zinc ions to bacitracin A, Biochemistry 19 (14): 3348-52. Biochrom AG Internet: www.biochrom.de page 2 of 7

table 3 and 4: details on the antibiotics G 418-BC, Gentamycin-sulfate (Gentamicin) G 418-BC A 291-25 10 g A 2912 (liquid, ready for use) molecular formula C 20H 40N 4O 10-2H 2SO 4 CAS no. 108321-42-2 molecular weight 692.7 g/mol bacteria, fungi, yeasts, protozoa, and mammalian cells 5 6, suited for the selection of transfected eukaryotic cells working concentration 50-1000 µg/ml maximum solubility 10-50 mg/ml in buffers or culture medium, storage at -20 C stability stable in solution at 2-8 C for 6 months Inhibits protein synthesis by disturbing the ribosome function. Micromonospora rhodorangea Gentamycin-sulfate (Gentamicin) A 2710 (lyophilised) 1x (6x5 ml) A 2712 A 271-23 2.5 g A 271-25 10 g A 271-26 25 g molecular formula C 19-21H 39-43N 5O 7 x 2,5 H 2SO 4 CAS no. 1405-41-0 molecular weight 694.75-723.75 g/mol; complex of three chemically similar gentamicins: C 1, C 2 and C 1a 7 Gram-positive and Gram-negative bacteria and Mycoplasma 8 working concentration 15-50 µg/ml maximum solubility 10-250 mg/ml in H 2O, storage at -20 C stability 1 5 days at 37 C 3 mg/ml Inhibits protein biosynthesis by binding to the 30 S ribosomal sub and by destroying the cell membrane 9. Micromonospora purpurea 5 Waitz, J. A. et al. (1974): Biological Activity of Antibiotic G-418, a New Micromonospora-Produced Aminoglycoside with Activity Against Protozoa and Helminths, Antimicrob Agents Chemother 6 (5): 579-581. 6 Panchal, C.J et al. (1984): Susceptibility of Saccharomyces spp. and Schwanniomyces spp. to the Aminoglycoside Antibiotic G418, AEM 47 (5): 1164-1166. 7 Weinstein, M. J et al. (1967): Biological Activity of the Antibiotic Components of the Gentamicin Complex, J Bact 94 (3): 789-790. 8 Rudin, A. et al. (1970): Antibacterial Activity of Gentamicin Sulfate in Tissue Culture, Appl Microbiology 20 (6): 989-990. 9 Kadurugamuwa, J. et al. (1993): Surface Action of Gentamicin on Pseudomonas aeruginosa, J Bact 175 (18): 5798-5805. Biochrom AG Internet: www.biochrom.de page 3 of 7

table 5, 6 and 7: Kanamycin, Neomycin and Partricin Kanamycin A 2512 (5 mg/ml) molecular formula C 18H 36N 4O 11 x H 2SO 4 CAS no. 25389-94-0 molecular weight 582.58 g/mol, mixture of Kanamycin A and < 5 % Kanamycin B Gram-positive and Gram-negative bacteria, as well as Mycoplasma working concentration 50-100 µg/ml maximum solubility 10 mg/ml in H 2O stability 1 5 days at 37 C 10 mg/ml Binds to the 30 S ribosomal sub, thus inhibiting protein biosynthesis 10. Streptomyces kanamyceticus Neomycin A 2412 (combination Neomycin/Bacitracin) molecular formula C 23H 46N 6O 13 x 3H 2SO 4 CAS no. 1405-10-3 molecular weight 908.88 g/mol, mixture of Neomycin B and C Gram-positive and Gram-negative bacteria working concentration 50 µg/ml maximum solubility 100 mg/ml in H 2O or methanol, storage at -20 C stability 1 at 37 C, 5 days toxicity 3 mg/ml Inhibits protein biosynthesis, inhibits phospholipase C and D 11 Streptomyces fradiae Partricin A 2812 molecular formula C 79H 119O 31N 5 CAS no. - molecular weight 1634.8 g/mol polyene antimycotic fungi and yeasts 12 working concentration 0,5 µg/ml maximum solubility 50 µg/ml in H 2O stability 1 3 days at 37 C Inhibits proliferation Streptomyces aureofaciens 10 Masukawa, H. (1969): Localization of Sensitivity to Kanamycin and Streptomycin in 30S Ribosomal Proteins of Escherichia Coli, J Antibiotics 22 (12):612-623. 11 Liscovitch, M. et al. (1991): Inhibition of neural phospholipase D activity by antibiotics, Biochem J 279: 319-321. 12 Rimaroli C. and Bruzzese T. (1998): In Vitro Activity of a New Polyene, SPA-S-843, against yeast, Antimicrob Agents Chemother 42 (11): 3012-3013. Biochrom AG Internet: www.biochrom.de page 4 of 7

table 8, 9 and 10: details on Penicillin, Polymyxin B-sulfate and Streptomycin-sulfate; Pen/Strep Penicillin A 321-42 25 mil. U A 321-44 100 mil. U molecular formula C 16H 17N 2NaO 4S CAS no. 69-57-8 molecular weight 356.4 g/mol β-lactam Gram-positive bacteria working concentration 20-100 µg/ml or 100 U/ml maximum solubility 10-100 mg/ml in H 2O stability 1 at 37 C, 3 days 10 mg/ml Inhibits the last cell wall synthesis, connects peptidoglycan strands by irreversibly interacting with transpeptidase 13 Penicillium chrysogenum (previously known as Penicillium notatum) Polymyxin B-sulfate A 231-40 5 mil. U molecular formula C 55H 96N 16O 13 x 2H 2SO 4 CAS no. 1405-20-5 molecular weight 1385.63 g/mol polypeptide only Gram-negative bacteria, also against non-proliferating bacteria working concentration 5-500 µg/ml maximum solubility 10-20 mg/ml in H 2O or methanol, storage at -20 C stability 1 5 days at 37 C 3 mg/ml Binding to lipopolysaccharides of the Gram-negative bacteria leads to a permeabilisation of the cell membrane 14. This results in loss of ions (Fe 2+, Mn 2+, Ca 2+, Mg 2+ ), unsaturated fatty acids and polyphosphate. Bacillus polymyxa Streptomycin-sulfate A 331-26 25 g A 331-27 100 g molecular formula (C 21H 39N 7O 12) 2-3H 2SO 4 CAS no. 3810-74-0 molecular weight 1457.4 g/mol primarily Gram-negative bacteria and Mycobacteria working concentration 10-100 µg/ml maximum solubility 10-50 mg/ml in H 2O stability 1 3 days at 37 C 20 mg/ml Inhibits initiation of the protein biosynthesis 15 Streptomyces griseus combination Pen/Strep A 2210 (lyophilised) 1x (6x5 ml) A 2212 (liquid) A 2213 (liquid) 100 ml 13 Izaki, K. et al. (1966): Glycopeptide Transpeptidase and D-Alanine Carboxypeptidase: Penicillin-Sensitive Enzymatic Reactions, Proc Natl Acad Sci 55 (3): 656-663. 14 Koike, M. et al. (1968): Electron Microscopic Studies on Mode of Action of Polymyxin, J Bact 97: 448-452. 15 Luzzatto, L. et al. (1968): Mechanism of Action of Streptomycin in E.coli: Interruption of the Ribosome Cycle at the Initiation of Protein Synthesis, Proc Natl Acad Sci 60 (3): 873 880. Biochrom AG Internet: www.biochrom.de page 5 of 7

3 Frequently asked questions about antibiotics 3.1 How do I notice a contamination? The medium turns cloudy. If the medium contains phenol red as ph indicator, the colour of the medium changes from red to yellow-orange in most cases, as the metabolites of the microorganisms accumulate, resulting in a change of the ph-value. Contaminated cultures may also be identified by a variation of the odour. The use of a microscope ensures a very quick identification of microorganisms (except for mycoplasma). 3.2 The culture has been contaminated despite preventive treatment with antibiotics. What may be the reasons? There are several reasons: a. The dose of the antibiotic in the medium is too low. The individual working concentration of the antibiotic in the medium differs (see tables above) and should be maintained as precisely as possible. b. In addition, antibiotics in the medium, depending on the respective antibiotic, remain stable at 37 C for approx. 3 to 5 days. At refrigeration temperatures between 2 and 8 C, antibiotics show more stability. Culture medium that has been supplemented by antibiotics should, however, not be kept in a refrigerator too long. For example, if a culture is to grow over a period of five days, an appropriately stable antibiotic needs to be used. Pen/Strep remains stable for only three days. Due to its spectrum, Kanamycin (see tables above) may represent an alternative to Pen/Strep, as it remains stable for five days. c. The antibiotic used is not effective because the microorganisms have mutated and are now resistant against the antibiotic (to continue see point 3.4). 3.3 What happens if the antibiotics have been dosed too high? Antibiotics that have been dosed too high may be toxic. As a result, cells die off. Working concentration values for the individual antibiotics substances are to be exactly adhered. 3.4 May the microorganisms become resistant during treatment? During treatment, microorganisms may mutate and become resistant against the antibiotic used. You may prevent such resistance in the case of long-term cultures by stopping the use of antibiotics completely for two or three passages. 3.5 May antibiotics successfully eliminate Mycoplasma? Mycoplasma considerably impairs cell proliferation through nutrient competition and cytotoxic secretion. Test-positive cultures often have to be rejected, as treatments with antibiotics are usually too complex or ineffective. In order to eliminate contaminations caused by Mycoplasma, antibiotics are used that feature high stability in the culture medium and are less toxic at low concentrations, such as Kanamycin ( A 2512). To do so, the culture medium is supplemented with 100 µg/ml Biochrom AG Internet: www.biochrom.de page 6 of 7

Kanamycin ( A 2512). To do so, the culture medium is supplemented with 100 µg/ml Kanamycin. Our recommendation: As an effective alternative to antibiotics, Biochrom AG recommends the Mynox elimination reagent, which immediately kills Mycoplasma and acts on a biophysical basis (for more information go to http://www.biochrom.de/en/products/mycoplasmareagents/.) 3.6 How may I check if the treatment was successful? Cultivate the cell culture for one or two passages without adding antibiotics. Biochrom AG Internet: www.biochrom.de page 7 of 7